BCI LifeSciences

Biotechnology Research • Manhattan, New York, United States • 1-10 Employees

Company overview

Headquarters	99 Park Avenue, New York, New York 10016, US
Website	bcilifescienceadvisors.com
SIC	873
Employees	1-10

Key Contact at BCI LifeSciences

Douglas Hulse

Co-Founder, Member of Board of Managers and Chief Executive Officer

BCI LifeSciences Email Formats

BCI LifeSciences uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@bcilifescienceadvisors.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@bcilifescienceadvisors.com	100%

About BCI LifeSciences

BCI LifeSciences LLC is an advisory firm, comprised of distinguished senior level executives from the life sciences industry. Its team members have advanced operating and transaction experience in biotechnology, pharmaceuticals, medical devices and clinical diagnostics, and its principals have been founders, chairmen, presidents, CEOs and COOs of large multi-national organizations and emerging healthcare companies in the United States and abroad. BCI LifeSciences has extensive experience advising companies and management teams in the life sciences industry from start-ups to multinationals, worldwide. BCI LifeSciences LLC maintains a close working relationship with its sister company, Bankers Capital International. Bankers Capital International is a boutique investment bank, headquartered in New York City, focused on multiple sectors in the United States, Asia, Europe, and Latin America. The firm advises middle-market clients on matters such as mergers and acquisitions, management buy-outs, capital raises, restructurings, turnarounds, and strategic planning. Bankers Capital International is registered with the Securities and Exchange Commission (SEC), and the Financial Industry Regulatory Authority (FINRA). The firm is also a member of the Securities Investor Protection Corporation (SIPC).

BCI LifeSciences revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding